These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 20205492)

  • 21. The timing of influenza vaccination for older adults (65 years and older).
    Lee BY; Tai JH; Bailey RR; Smith KJ
    Vaccine; 2009 Nov; 27(50):7110-5. PubMed ID: 19786135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of universal influenza vaccination in a pregnant population.
    Roberts S; Hollier LM; Sheffield J; Laibl V; Wendel GD
    Obstet Gynecol; 2006 Jun; 107(6):1323-9. PubMed ID: 16738159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economic value of seasonal and pandemic influenza vaccination during pregnancy.
    Beigi RH; Wiringa AE; Bailey RR; Assi TM; Lee BY
    Clin Infect Dis; 2009 Dec; 49(12):1784-92. PubMed ID: 19911967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of quadrivalent influenza vaccine in Hong Kong - A decision analysis.
    You JH; Ming WK; Chan PK
    Hum Vaccin Immunother; 2015; 11(3):564-71. PubMed ID: 25714506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. From the patient perspective: the economic value of seasonal and H1N1 influenza vaccination.
    Lee BY; Bacon KM; Donohue JM; Wiringa AE; Bailey RR; Zimmerman RK
    Vaccine; 2011 Mar; 29(11):2149-58. PubMed ID: 21215340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-Effectiveness and Health Impacts of Different Influenza Vaccination Strategies for Children in China.
    Gong Y; Yao X; Peng J; Ma Y; Fang Y; Yan K; Jiang M
    Am J Prev Med; 2023 Jul; 65(1):155-164. PubMed ID: 37037733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-Effectiveness of Quadrivalent versus Trivalent Influenza Vaccine in the United States.
    de Boer PT; Crépey P; Pitman RJ; Macabeo B; Chit A; Postma MJ
    Value Health; 2016 Dec; 19(8):964-975. PubMed ID: 27987647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cost-effectiveness of vaccinating pregnant women against seasonal influenza in England and Wales.
    Jit M; Cromer D; Baguelin M; Stowe J; Andrews N; Miller E
    Vaccine; 2010 Dec; 29(1):115-22. PubMed ID: 21055501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Household-based costs and benefits of vaccinating healthy children in daycare against influenza virus: results from a pilot study.
    Pisu M; Meltzer MI; Hurwitz ES; Haber M
    Pharmacoeconomics; 2005; 23(1):55-67. PubMed ID: 15693728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis.
    Rothberg MB; Rose DN
    Am J Med; 2005 Jan; 118(1):68-77. PubMed ID: 15639212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.
    Piedra PA; Gaglani MJ; Kozinetz CA; Herschler GB; Fewlass C; Harvey D; Zimmerman N; Glezen WP
    Pediatrics; 2007 Sep; 120(3):e553-64. PubMed ID: 17698577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccinating children against influenza: overall cost-effective with potential for undesirable outcomes.
    de Boer PT; Backer JA; van Hoek AJ; Wallinga J
    BMC Med; 2020 Jan; 18(1):11. PubMed ID: 31931789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of an influenza vaccination program offering intramuscular and intradermal vaccines versus intramuscular vaccine alone for elderly.
    Leung MK; You JH
    Vaccine; 2016 May; 34(22):2469-76. PubMed ID: 27079928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of 2009 pandemic influenza A(H1N1) vaccination in the United States.
    Prosser LA; Lavelle TA; Fiore AE; Bridges CB; Reed C; Jain S; Dunham KM; Meltzer MI
    PLoS One; 2011; 6(7):e22308. PubMed ID: 21829456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concurrent and cross-season protection of inactivated influenza vaccine against A(H1N1)pdm09 illness among young children: 2012-2013 case-control evaluation of influenza vaccine effectiveness.
    Fu C; Xu J; Lin J; Wang M; Li K; Ge J; Thompson MG
    Vaccine; 2015 Jun; 33(25):2917-21. PubMed ID: 25921713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of Public Health and Economic Impact of Intranasal Live-Attenuated Influenza Vaccination of Children in France Using a Dynamic Transmission Model.
    Gerlier L; Lamotte M; Grenèche S; Lenne X; Carrat F; Weil-Olivier C; Damm O; Schwehm M; Eichner M
    Appl Health Econ Health Policy; 2017 Apr; 15(2):261-276. PubMed ID: 27943165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of influenza vaccination of healthy children.
    Salo H; Kilpi T; Sintonen H; Linna M; Peltola V; Heikkinen T
    Vaccine; 2006 Jun; 24(23):4934-41. PubMed ID: 16678945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Universal influenza vaccination and live attenuated influenza vaccination of children.
    Glezen WP
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S104-9. PubMed ID: 18820568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influenza vaccination health impact and cost effectiveness among adults aged 50 to 64 and 65 and older.
    Maciosek MV; Solberg LI; Coffield AB; Edwards NM; Goodman MJ
    Am J Prev Med; 2006 Jul; 31(1):72-9. PubMed ID: 16777545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends in U.S. pediatric influenza vaccination from 2006 to 2010 among children with private insurance.
    Toback SL; Herley J; Edelman L; Ambrose CS
    Vaccine; 2011 Jun; 29(25):4225-9. PubMed ID: 21497635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.